Join us for this insightful session exploring the myelofibrosis patient journey from diagnosis through to long-term management. Hear how symptom burden, anaemia, and cytopenia impact patients’ quality of life, and gain practical knowledge on the latest treatment approaches, including the role of JAK inhibitors.